🇺🇸 FRACTYL HEALTH, INC.GUTS
Get FRACTYL HEALTH, INC. filings on Telegram the moment they are published.
Follow FRACTYL HEALTH, INC. on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 8-K Items 7.01, 8.01, 9.01
Overview: Announced positive six-month REMAIN-1 study results for Revita, meeting its co-primary endpoint with 80% retention of GLP-1 induced weight loss versus 67% for sham.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest